Gangrene (Putrefaction of Tissues): A Condition Caused by the Death of Tissue Due to Poor Blood Flow or External Bacterial Invasion, including its Pathogenesis, Epidemiology, Present State, and Effective Treatment Strategies

Abstract

Gangrene is a life-threatening illness that can result in morbidity and death for those who have it. It is also difficult to treat. In this article, gangrene is often categorised as wet or dry. People have been diagnosed with gangrene for many years due to a variety of conditions, including diabetes mellitus, peripheral artery disease, infection, and insufficient blood supply. The Greek term gangraina, which means "putrefaction of tissues," and the Latin word gangraena are the sources of the etymology of gangrene. Since certain species of maggots only eat dead flesh, leaving surrounding living tissue intact, flies and maggots were frequently utilised to treat chronic wounds or ulcers as early as 1028 to stop or prevent necrotic spread. After antibiotics were included to the list of wound treatments, this practice essentially vanished. However, maggot therapy has earned some credence recently and is occasionally used quite effectively in cases of persistent tissue necrosis. When Jean-Baptiste Lully, a French Baroque composer, stabbed his own toe with his pointed staff (which served as a baton) during a performance of his Te Deum in January 1687, he developed gangrene. Insulin and antibiotics are used to treat gangrene, and they are somewhat successful. However, this review focuses on gangrene and shows how to treat it, which is most likely to be curative. The genesis, aetiology, diagnosis, treatment, and consequences of gangrene are all discussed.

Keywords

Introduction

A medical emergency known as gangrene occurs when blood stops flowing to a particular location of your body, causing the tissues there to die. Although gangrene can appear anywhere on your body, it usually begins in the hand or foot. Tissue necrosis brought on by ischemia or infection is a hallmark of gangrene. Dry, moist, and gas gangrene are the three primary classifications for the disorder. Circumferential necrosis is frequently caused by dry gangrene, which usually arises from increasing ischemia and is particularly noticeable in the digits. The afflicted tissue dries out and might self-amputate. The term "wet gangrene" describes necrotic tissue that has been worsened by a subsequent infection and usually affects the lower limbs. Erythema, purulent discharge, and oedema are the condition's symptoms. Gas-forming bacteria, most frequently Clostridium species, produce gas gangrene, a necrotising infection that progresses quickly and can be fatal. When blood cannot reach a certain part of your body, but there is no infection, you have dry gangrene. There won't be any open blisters or pus, and your skin will feel dry to the touch. Dry gangrene is often caused by atherosclerosis, or plaque accumulation in your arteries. Wet gangrene: This is caused by both a bacterial infection and impaired blood flow. Your skin develops blisters that leak pus, which is the "wet" element.¹ Wet gangrene spreads swiftly to adjacent tissues. Gas gangrene: Your blood cells and soft tissues are destroyed by this bacterial infection. In your muscle tissue, bacteria grow rapidly, producing gas and poisons. Within hours of the onset of symptoms, the illness can turn fatal due to its rapid spread. A rare and serious bacterial infection that affects the vaginal area is called Fournier's gangrene. Males are more frequently affected than females.

Internal gangrene: This occurs when the blood supply to internal organs is obstructed. Your gallbladder, intestines, or appendix are among the organs that may be impacted. A dangerous side effect of chronic cholecystitis is a gangrenous gallbladder, in which tissue death results from persistent swelling. Tissue necrosis brought on by ischemia or infection is a hallmark of gangrene. Dry, moist, and gas gangrene are the three primary classifications for the disorder. Circumferential necrosis is frequently caused by dry gangrene, which usually arises from increasing ischemia and is particularly noticeable in the digits. The afflicted tissue dries out and might self-amputate. The term "wet gangrene" describes necrotic tissue that has been worsened by a subsequent infection and usually affects the lower limbs. Erythema, purulent discharge, and oedema are the condition's symptoms. Gas-forming bacteria, most frequently Clostridium species, produce gas gangrene, a necrotising infection that progresses quickly and can be fatal. Oedema, crepitance, and dishwater discharge involving the muscular, fascial, and subcutaneous compartments are among the clinical manifestations. Radiographic imaging may show gas. Gas gangrene frequently develops in patients with peripheral vascular disease, renal illness, diabetes, trauma, cancer, or intra-abdominal pathology. Due to pain, decreased mobility, and repeated hospital stays, gangrene can seriously lower a patient's quality of life.² Men are more frequently impacted by amputations than women. Functional capacity may be significantly impacted by the ensuing tissue loss. Significant morbidity and mortality are frequently associated with numerous surgical procedures and a higher chance of dying as the illness worsens. The death rate from gas gangrene is high, especially in individuals who have sepsis, hyperglycemia, or leukocytosis. The ankle-brachial index, Doppler ultrasound, computed tomography, magnetic resonance imaging, and certain laboratory markers are examples of supportive diagnostic techniques. Although there is yet no evidence to support them, experimental treatments such as hyperbaric oxygen, growth factors, stem cell therapies, broad-spectrum antibiotics, and, in certain situations, intravenous immunoglobulin are also discussed. In the end, improving survival and maintaining function in patients with gangrene depend heavily on prompt diagnosis and coordinated care. This exercise gives medical professionals a thorough understanding of evidence-based gangrene management procedures, including supportive care, surgical intervention, antimicrobial therapy, and revascularisation approaches. In order to maximise results and reduce complications like amputation and sepsis, primary clinicians, surgeons, infectious disease specialists, and wound care providers must coordinate their care. This activity also emphasises the significance of collaboration among the interprofessional healthcare team.^3,4

Fig.1 Gangrene

EPIDEMIOLOGY

Peripheral vascular disease, which is mostly caused by arterial insufficiency, has an annual incidence of gangrene of about 16.7%. The risk rises with age and concomitant conditions such as diabetes, hypertension, and smoking. In the US, people 50 years of age or older have a 1% incidence of critical limb ischemia, and people 70 years of age or older have a greater frequency. Over 200 million people worldwide suffer from lower extremity peripheral arterial disease, and 10% of them experience critical limb ischemia. Five to ten per cent of those with intermittent claudication or asymptomatic peripheral artery disease develop critical ischemia over five years. Every year, about 1000 instances of clostridial gas gangrene are documented in the US; half of these cases are caused by trauma, 30% are the result of surgery, and 20% develop on their own. Affected people are typically approximately 70 years old, and they frequently have concomitant conditions, including diabetes and peripheral vascular disease. Trauma, contaminated surgery, intravenous drug use, animal or insect bites, enterocutaneous fistulae, abscesses, urinary tract infections, immunodeficiency, throat streptococcal infections, and anticoagulant usage are all major causes of infections. Hematogenous spread has also been linked to nontraumatic gas gangrene, and some case investigations have shown a correlation with a metastatic gastrointestinal cancer. While polymicrobial infections usually affect people 60 years of age or older, infections caused by a single germ, such as Staphylococcus or Streptococcus, are more common in younger patients.^5-10

ETIOLOGY

As a final stage of peripheral vascular disease, dry gangrene is most frequently caused by atherosclerosis and the gradual blockage of arterial circulation to distal tissue. People who smoke, have diabetes, high blood pressure, or high cholesterol are at greater risk. In hypercoagulable conditions, arterial thrombosis may occur in situ. Atherosclerotic plaque rupture can cause occlusion and thrombosis, whereas embolic events can cause distal occlusion. Limb ischemia can be made worse by conditions that raise local perfusion demands, such as trauma, intravenous drug use, focused infection, and failed vascular surgery. Furthermore, acute ischemia and gangrene can be brought on by vasculitis, adventitial cystic disease, popliteal artery entrapment, and Burger disease. Even when peripheral circulation appears to be completely normal, diabetes can cause microvascular dysfunction, which puts people at risk for ischemia. Gangrene awareness may be diminished by diabetic neuropathy when microthrombosis and acute large-vein thrombosis coexist in the same limb, frequently in the context of a hypercoagulable state, venous limb gangrene results. Sickle cell anaemia, autoimmune diseases, chronic myeloid leukaemia (CML), and other haematological malignancies are less frequent causes of dry gangrene. Additionally, a case of thrombocytosis resulting in digit gangrene has been documented. When type I cryoglobulinemia, which is caused by circulating immunoglobulin M (IgM), is present, lymphoplasmacytic lymphoma, a type of B-cell lymphoma, can lead to vascular blockage and dry gangrene. Even with sufficient circulation, many limbs may develop gangrene at the same time, as is the case with purpura fulminans linked to septicemia from Neisseria meningitidis. Since bacteria cannot grow in mummified tissue, dry gangrene is frequently aseptic. When tissue with reduced venous or arterial blood flow becomes infected, wet gangrene results. Although it can also affect genitourinary and oral tissues, this ailment most frequently affects areas that are prone to oedema, such as the lower extremities.^11,12 Due to hyperglycemia, which hinders wound healing and increases inflammation, patients with diabetes are more vulnerable to wet gangrene. Infection with Clostridium perfringens and other Clostridium species frequently results in gas gangrene, which causes myonecrosis. Strong exotoxins are produced by the anaerobic, spore-forming Clostridium species of bacteria. Deeper muscle layers are infected by these poisons, which spread quickly and significantly increase mortality. Sepsis and fast tissue necrosis can be brought on by exotoxins. This quick development adds to the high death rate linked to gas gangrene. Gas gangrene is frequently caused by trauma (historically linked to combat injuries), cancer, retained placenta, intrauterine fetal mortality, intramuscular injections, and bowel or biliary tract procedures. While C septicum can occur spontaneously or be linked to gastrointestinal gateways, C perfringens is frequently linked to trauma. Gynaecological origins are linked to C novyi, C histolyticum, and C sordelli. Furthermore, eating contaminated seafood or having open wounds can result in infection from Vibrio vulnificus, which is frequently found in warm coastal waters. Escherichia coli, Bacteroides, Staphylococcus epidermidis, and Streptococcus species are additional gas-producing bacteria that can cause both local and systemic illnesses. Type I necrotising fasciitis is a polymicrobial bacterial infection including both aerobic and anaerobic organisms, that can also produce gas within tissues. It is characterised by friable superficial fascia, dishwater-grey exudate, and lack of pus.^13-15

PATHOPHYSIOLOGY

Numerous causes, such as ischemia, tumour antigen–antibody complexes, hyperviscosity, immunological dysregulation, circulating procoagulant factors, and skin integrity degradation, can lead to gangrene. Platelet sludge and thromboxane-mediated platelet aggregation may cause increased blood viscosity. IgM cryoglobulin intravascular deposits play a role in the development of gangrene in diseases such as lymphoplasmacytic lymphoma. Furthermore, penetrating injuries generate an anaerobic environment that promotes the growth of anaerobic bacteria.

Chronic hyperglycemia and atherosclerotic plaque worsen atherosclerosis and cause endothelial dysfunction, which weakens the immune system and makes a person more vulnerable to infection. Endothelial damage and distal oedema come from compensatory arteriolar dilatation brought on by decreased perfusion. Microthrombosis may be triggered by this cascade, worsening ischemia and reducing tissue perfusion. Localised cellular dysregulation prevents proper wound healing because of the ischemic environment, which prolongs tissue damage and raises the risk of infection. Tobacco products contain substances that cause vasoconstriction, plaque formation, and inflammation, all of which directly damage blood vessels. Excess cholesterol leads to plaque buildup, artery narrowing, and blood hyperviscosity, whereas hypertension raises the risk of thromboembolism. Devitalized tissue frequently has a compromised immune response, which raises the risk of sepsis and abscess formation.^16,17 It is also vulnerable to microbial infiltration, especially fungal infections. Microbial invasion is made possible by defects in the small intestinal mucosa brought on by cancer, radiation, chemotherapy, surgery, deep wounds (usually linked to C perfringens), and common pathways or entry locations for C septicum. Gases like nitrogen, hydrogen, hydrogen sulfide, oxygen, and carbon dioxide are released by bacteria that flourish in acidic, ischemic settings and can travel quickly along muscle fibre planes. Multiple toxins produced by bacteria, including C perfringens and group A Streptococcus, can cause local tissue damage and later systemic infection, greatly increasing mortality. Group A beta-hemolytic Streptococcus M proteins help the bacteria attach to tissue and avoid immunological mediators. Additionally, they can activate T cells, which might set off a harmful inflammatory reaction. Clostridium septicum's primary toxin, alpha toxin, is released in an inactive form that attaches to the membrane of the host cell, creates a pore, and lyses the cell. C perfringens produces an alpha toxin that is a zinc-dependent metallophospholipase with phospholipase C and sphingomyelinase activity. In addition to increasing vascular permeability and impairing cardiac function, this results in muscle necrosis and hemolysis, bradycardia, and hypotension. Alpha toxin variations, such as beta-, gamma-, and delta toxins, contribute to systemic hemolysis and gangrene in addition to causing widespread tissue necrosis. Furthermore, endotoxins encourage platelets, leukocytes, and endothelial cells to aggregate, resulting in thrombosis. Additionally, endotoxins hinder neutrophil activity and leukocyte migration into hypoxic and diseased tissues.¹⁸

COMPLEXITIES

In addition to claudication, rest discomfort, pallor, cool skin temperature, paresthesias, neuropathy, and ulceration, dry gangrene usually manifests as severe pain that is characterised as throbbing or searing. Patients frequently report increasing limb discomfort that becomes better while the leg is in a dependent posture and gets worse when elevated. Tissue loss may be the initial sign of ischemia in people with underlying neuropathy.[6] Additional signs of dry gangrene include headache, priapism, dizziness, and impaired mental status, depending on the underlying illness. A physical examination may reveal anything from skin necrosis to livedo reticularis. When the diseased limb is lowered, patients with ischemic gangrene may have dependent rubor, and when the leg is raised, they may show pallor. Distal pulses are generally not perceptible, capillary refill is commonly delayed, and hair may be lost. Venous ulcers typically form over the malleoli, whereas arterial ischemia frequently results in ulcerations on the toes and distal foot. Pressure-bearing areas frequently develop neuropathic ulcers. A thorough physical examination should measure the depth of any ulcerations and assess sensory loss. Severe acute limb ischemia manifests as severe lower extremity pain, paralysis of the affected limb, and sensory loss ranging from modest at the toes to permanent, diffuse nerve damage. In the context of an ischemic or diabetic ulcer, or a similar condition, wet gangrene manifests as drainage and oedema. Bullae, ecchymosis, crepitus, and paresthesia may have been present together with cellulitis or a contained purulent region that gradually turns discoloured. There may also be systemic infection symptoms. A deeper abscess may occasionally be indicated by isolated soreness over intact skin, and the location is usually uncomfortable.¹⁹ Any areas of concern should be carefully assessed utilising the proper imaging and laboratory testing. The symptoms of gas gangrene can vary widely, from obvious skin changes and discomfort to vague malaise or fulminant sepsis. Although ambiguous early signs can postpone diagnosis, patients frequently have a recent history of trauma or surgery. Severe discomfort that is out of proportion to physical findings and frequently goes beyond obvious skin changes is a common complaint. Oedema, erythema, hemorrhagic bullae, ecchymosis, necrosis, subcutaneous emphysema, and skin colouring ranging from light to purplish are possible additional symptoms. Findings may include paresthesias, increasing erythema and oedema, and crepitus as the illness worsens. Within 24 to 72 hours of damage, an erythematous lesion may develop into dusky skin with hemorrhagic bullae on top. Reducing mortality, which increases dramatically as skin changes become more noticeable, requires maintaining a high level of clinical suspicion. An instance of an intrusive group. An infant's streptococcal illness caused myositis, dry gangrene, and disseminated intravascular coagulation, which finally necessitated amputation. Gangrene affecting the proximal foot, leg, and toes was linked to ischemia in the femoral artery distribution in a study looking at the connection between clinical signs of dry gangrene and Doppler ultrasound findings. On the other hand, popliteal artery obstruction was associated with gangrene restricted to the toes and distal foot. Long-term vasopressor use can potentially result in ischemic gangrene, which can need amputation and reconstructive procedures to maintain optimum sensory and functional capacity. Recurrences of diabetic moist gangrene of the foot are common, and ray amputations are more likely to result in further amputations than isolated toe amputations. Long-term hospital stays, amputations, and other treatments that result in tissue loss and functional impairment are all consequences of gangrene. In certain circumstances, limb recovery is attempted; nevertheless, amputations that are anatomically favourable can make a prosthesis easier to operate. According to retrospective research, 29% of patients with above-the-knee amputations and 65% of patients with below-the-knee amputations are still ambulatory after a year. Two years after below-the-knee amputation, 15% of patients had contralateral amputations, 15% had above-the-knee amputations, and 30% had passed away, according to observational studies. Up to 50% of diabetic patients will have an amputation within a year of receiving a diagnosis of critical limb ischemia or chronic limb-threatening ischemia, and 20% to 25% will pass away. Amputation rates are 19% at six months and 23% at twelve months in nondiabetic patients with rest discomfort, ischemic ulcers, or gangrene, according to other observational studies. An infection that is incurable is the most frequent reason for amputation. After revascularisation, patients are usually observed for at least two years to check for recurrence. Gas gangrene has a high death rate and frequently presents as early sepsis. Gas gangrene can kill up to 25% of trauma patients, and if diagnosis and treatment are postponed, death might reach 100%. the possibility of illness and death. To promote healing and prevent recurrence, patients who have been treated for gangrene or who are at risk of developing it should be educated on correct foot and wound care.²⁰ To stop gangrene from developing undetected, it is crucial to teach early detection of ischemia alterations or inflammatory symptoms. People who have fever, erythema, disproportionate pain, or soreness should get checked out and treated once. Patients who have comorbidities or risk factors for gangrene need to be informed about the condition's symptoms, indicators, and potentially lethal consequences. Optimising therapeutic results requires early detection of ischemic tissue, whether from peripheral vascular disease or infection. Before tissue loss begins, people at risk for peripheral artery disease can be identified with the aid of a thorough history, physical examination, documented results of noninvasive tests, and pertinent imaging.  Validated classification systems let interdisciplinary teams communicate uniformly about disease stages and treatment planning if ischemia is identified. Coordinated resource management and a multidisciplinary strategy combining qualified nurses, wound care specialists, and surgeons with expertise in general, vascular, and plastic surgery are necessary for the care of patients with gangrene. Mortality is greatly increased by delays in diagnosis and treatment, particularly those that last longer than 24 hours following admission. Improving patient outcomes requires prompt cooperation and intervention.²¹

MONITORING

For the purpose of staging critical or chronic limb ischemia, several classification schemes are available. In order to provide prognostic guidance and inform treatment options, including the expected effectiveness of revascularisation, the Society for Vascular Surgery categorisation takes into account the characteristics of the wound, the degree of ischemia, and the existence of foot infection. A scale of 0 to 3 is used to grade wounds. Grade 1 denotes mild tissue loss that can be treated with targeted amputation or local debridement. A transmetatarsal amputation or several digital amputations are usually used to treat grade 2 gangrene, which is restricted to the digits. A more proximal amputation is necessary because of the significant tissue loss indicated by grade 3. Patients are categorised according to the anticipated benefits of revascularisation and their risk of amputation. Peripheral vascular disease is categorised using a number of different staging schemes. Clinical manifestations ranging from intermittent claudication to ulceration and gangrene are categorised using the Rutherford classification, which has a range of 0 to 6. Based on symptoms and functional impairment, the Fontaine classification employs a scale from 1 to 4, with stage 1 denoting early disease with mild symptoms and stage 4 denoting late disease, including gangrene.²² The Wagner ulcer classification, which ranges from 0 to 5—0 denoting no ulceration and 5 denoting significant gangrene—is frequently used for diabetic ulcers. A vital tool for the early detection of arterial insufficiency is the ankle-brachial index (ABI), which is deemed abnormal if it is less than 1.0. Ischemia is indicated by an ankle blood pressure reading of less than 40 to 60 mm Hg, and a value of less than 70 mm Hg in ischemic tissue is also abnormal. Ankle pressures, toe pressures, and transcutaneous oxygen readings are additional noninvasive tests that may be used when the ABI is equivocal, especially in people with diabetes or older persons due to vascular calcification and decreased compressibility. Areas of ischemia can be localised with the use of imaging modalities such as Doppler ultrasonography, digital subtraction angiography, computed tomography (CT) angiography, and magnetic resonance angiography. The evaluation of gangrene mostly relies on laboratory testing, imaging, and clinical evaluation. Although the diagnosis is mostly clinical, Gram stain and wound cultures can assist in identifying the culprit bacteria to direct antibiotic therapy when gas or wet gangrene is suspected. Because superficial swabs are frequently tainted by skin flora, cultures should be acquired by deep swabbing or aspiration of purulent discharge. The laboratory workup focuses on blood and wound cultures, as well as infection markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Diabetes, hyperlipidemia, and renal failure are further clinical signs of illness. While elevated interleukin-6, procalcitonin, and poor hematocrit are linked to higher mortality, particularly in patients with truncal involvement, elevated CRP levels are correlated with gas gangrene. To diagnose gangrene and its consequences, radiographic evaluation is essential. While CT can indicate intramuscular fluid accumulation or fascial thickening, plain X-rays may reveal subcutaneous gas. Soft tissue images with great resolution are provided by magnetic resonance imaging (MRI). MRI may show aberrant signal intensity in the deep fascia, while CT with contrast may show no fascial enhancement. Patients may be assessed under a bedside anaesthetic by local probing if the diagnosis is still unclear. Necrotising infections are characterised by the presence of "dishwater" fluid and quick fascial plane auto-dissection. Depending on the clinical situation, more tests may be necessary. An echocardiography can be used to evaluate right ventricular function and identify thrombus or pulmonary hypertension. Tissue perfusion is assessed with the aid of CT angiography. Diagnosis is aided by a bone biopsy in cases of suspected osteomyelitis or a bone marrow biopsy in cases of suspected myeloproliferative disease. When the cause of thrombosis is unknown, a hypercoagulability workup is recommended. Serum protein electrophoresis, beta-2 microglobulin, serum viscosity, HIV and hepatitis screening, and autoantibodies such as myelin-associated glycoprotein and ganglioside antibodies are examples of other laboratory testing. Reverse transcriptase polymerase chain reaction (RT-PCR) and other cytogenetic techniques can be used to identify genetic anomalies linked to CML, such as the BCR-ABL fusion gene.^23,24

SUPERVISION AND THERAPY

Gangrene can be treated with debridement, advanced wound care, amputation, and revascularisation. Restoring blood flow, reducing rest discomfort, and encouraging the healing of ischemic wounds are the main goals of managing ischemic gangrene. Catheter-based intravascular thrombolysis may be used in acute ischemia. Depending on the location of the lesion and the patient's comorbidities, revascularisation may be accomplished by endovascular procedures such as surgical bypass or balloon angioplasty (with or without stent implantation). Although complete tissue regeneration is improbable if ulcers develop into dry gangrene, medicinal and surgical procedures can reduce tissue loss. Amputation may be necessary, ranging from a guillotine amputation for defined necrosis or a ray amputation of a digit to more involved surgeries, such as below-the-knee or above-the-knee amputation with flap closure or repair, including muscle flap transfers as necessary. When there is severe necrosis of the weight-bearing part of the foot, refractory pain, uncontrolled infection or sepsis, paresis of the extremities, or a shortened life expectancy, amputation is advised before an attempt at revascularisation. If there is significant foot necrosis, above-ankle amputation is frequently advised.²⁵ About 1 in 12 cases may result in autoamputation, which is the spontaneous separation of unviable tissue from viable tissue. Because of the systemic effects of exotoxins, gas gangrene can develop quickly and has a high death rate if treatment is postponed. Prompt surgical debridement or amputation, broad-spectrum antibiotics, intravenous immunoglobulin to bind and neutralise toxins, and optimisation of concomitant diseases are all part of management. Patients receive treatment in accordance with sepsis procedures, which include organ dysfunction support and fluid resuscitation. For source control and successful therapy, early surgical investigation and debridement are essential, frequently necessitating numerous reevaluations and repeat debridements. Survival is greatly increased by surgery performed within 24 hours of arrival. Particularly extensive surgical debridement is required when gangrene affects the trunk. Toxins generated by Staphylococcus and Streptococcus species may also be bound and neutralised by intravenous immunoglobulin. Antiplatelet therapy with aspirin or clopidogrel and the control of hypertension with beta-blockers and angiotensin-converting enzyme inhibitors are two medical treatments for ischemic gangrene. Patients with diabetes are treated to a goal haemoglobin A1c (HbA1c) of less than 7%, and hyperlipidemia is treated with statins when necessary. Quitting smoking is essential for lowering the chance that an illness may worsen. Amputation is done for tissues that cannot be saved, while angioplasty or surgical bypass may be used to restore the blood supply. Hydroxyurea and subcutaneous heparin are used to treat dry gangrene caused by myeloproliferative diseases. Tyrosine kinase inhibitors like imatinib are used to treat CML. Bendamustine, rituximab, prednisone, and plasma exchange can all be used to treat circulating immune complexes. For leukaemia-induced thrombocytosis, leukapheresis is recommended. The antibiotic treatment for necrotizing soft tissue infections and gas gangrene should be tailored as soon as the causative organism is identified. Common treatments for clostridial infections include ampicillin-sulbactam or imipenem in conjunction with metronidazole and clindamycin, or vancomycin with piperacillin-tazobactam or a carbapenem. First, broad-spectrum coverage that targets anaerobic microorganisms and both gram-positive and gram-negative bacteria is essential. If group A Streptococcus or Clostridium organisms are discovered, the recommended course of treatment is penicillin plus clindamycin for ten to fourteen days. Because it helps stop the production of clostridial toxins, clindamycin is especially important for reducing toxin-mediated harm. However, clindamycin monotherapy is not recommended due to the increased likelihood of inducible resistance. Although hyperbaric oxygen therapy has been suggested as a treatment to raise oxygen tension in ischemic tissue, it is not beneficial for critical limb ischemia. Although there is no conclusive proof, it is hypothesised that hyperbaric oxygen may lower mortality. Growth factors and stem cell treatments that promote angiogenesis are further potential experimental therapeutics; however, there is a lack of clinical data, and these treatments are presently limited to clinical studies. Randomised controlled experiments have not demonstrated the effectiveness of intravenous immunoglobulin in neutralising exotoxins.^26-29

DISCUSSION AND CONCLUSION

In addition to giving a general overview of the illness, our review papers discuss the pathophysiology, epidemiology, diagnostics, alternative treatments, and other causes of gangrene. Although targeted drugs and other therapies can treat Gangrene, the rarest and most severe disease in the world, our findings indicate that further clinical research is required due to its complexity. To cure gangrene, more randomised controlled research is needed. We want to provide an initial assessment on Gangrene in the future. Future counseling-based study in our state or nation will evaluate patients' physical and emotional well-being with the help of our colleagues in order to provide more accurate information about Gangrene and its therapy.

ETHICAL STATEMENT

A pharmacist must behave honourably and truthfully. A pharmacist abstains from behaviours that compromise their commitment to acting in the best interests of their patients, such as unlawful behaviour, discriminatory acts, and unfavourable working conditions that impair judgment. A pharmacist maintains their level of proficiency.

ACKNOWLEDGEMENT

The authors would like to thank LOVELY PROFESSIONAL UNIVERSITY, JALANDHAR-DELHI, G.T. ROAD, PHAGWARA, PUNJAB (INDIA) -144411. (RESEARCH SCHOLAR), for extending their facilities.

CONFLICT OF INTEREST

The authors attest that they are free of any known financial or personal conflicts of interest that would taint the findings of this study.

INFORMED CONSENT     

Using websites, review articles, and other sources to produce research content.

REFERENCES

1. Patel D, Patel D, Parma D. A case report: pre-gangrene left foot with COPD and hypertension. J Drug Deliv Ther. 2023; 13(3):5-6.
2. Nair PS, Berihu TA, Kumar V. An image-based gangrene disease classification. International Journal of Electrical & Computer Engineering (2088-8708). 2020; 10(6): 6001~6007.
3. Rodrigues J, Mitt N. Diabetic Foot and Gangrene [Internet]. Gangrene - Current Concepts and Management Options. InTech; 2011. Available from: http://dx.doi.org/10.5772/23994
4. Pundkar A, Shrivastav S, Chandanwale R, Jaiswal AM, Goyal S. Vasopressin-Induced Gangrene of the Bilateral Foot Digits and Right Index Finger Managed With Platelet Rich Plasma Treatment. Cureus. 2024; 16(1):1-5.
5. Yachmaneni Jr A, Jajoo S, Mahakalkar C, Kshirsagar S, Dhole S. A comprehensive review of the vascular consequences of diabetes in the lower extremities: current approaches to management and evaluation of clinical outcomes. Cureus. 2023; 15(10):1-14.
6. Sushma M, Vidyadhar TV, Mohanraj R, Babu M. A review on gas gangrene and its management. PharmaTutor. 2014; 2(5):65-74.
7. Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. International journal of preventive medicine. 2014; 5(8):927.
8. Deshmukh CD, Jain A, Nahata B. Diabetes mellitus: a review. Int. J. Pure Appl. Biosci. 2015;3(3):224-30.
9. Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Inflammation in peripheral artery disease. Circulation. 2010;122(18):1862-75.
10. Haimovici H. Gangrene of the extremities of venous origin: review of the literature with case reports. Circulation. 1950; 1(2):225-40.
11. Bhangu G, Uminski K, Roessner C, Goodyear D, Sale T, Rydz N. Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report. Ann Hematol. 2024 Aug;103(8):3277-3279. [PubMed]
12. Rao AK, Syed F, Garrido D, Holladay CS, Saylors J. A Case of Type 1 Cryoglobulinemia With Lymphoplasmacytic Lymphoma and Dry Gangrene. Cureus. 2024 Jan;16(1):e52659. [PMC free article] [PubMed]
13. Al Wahbi A. Autoamputation of diabetic toe with dry gangrene: a myth or a fact? Diabetes Metab Syndr Obes. 2018;11:255-264. [PMC free article] [PubMed]
14. Leiblein M, Wagner N, Adam EH, Frank J, Marzi I, Nau C. Clostridial Gas Gangrene - A Rare but Deadly Infection: Case series and Comparison to Other Necrotizing Soft Tissue Infections. Orthop Surg. 2020 Dec;12(6):1733-1747. [PMC free article] [PubMed]
15. Brucato MP, Patel K, Mgbako O. Diagnosis of gas gangrene: does a discrepancy exist between the published data and practice. J Foot Ankle Surg. 2014 Mar-Apr;53(2):137-40. [PubMed]
16. Stevens DL, Bryant AE. Necrotizing Soft-Tissue Infections. N Engl J Med. 2017 Dec 07;377(23):2253-2265. [PubMed]
17. Lehner PJ, Powell H. Gas gangrene. BMJ. 1991 Jul 27;303(6796):240-2. [PMC free article] [PubMed]
18. Yang Z, Hu J, Qu Y, Sun F, Leng X, Li H, Zhan S. Interventions for treating gas gangrene. Cochrane Database Syst Rev. 2015 Dec 03;2015(12):CD010577. [PMC free article] [PubMed]
19. Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH., GVG Writing Group. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. [PMC free article] [PubMed]
20. Mills JL, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G., Society for Vascular Surgery Lower Extremity Guidelines Committee. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014 Jan;59(1):220-34.e1-2. [PubMed]
21. Singer AJ, Tassiopoulos A, Kirsner RS. Evaluation and Management of Lower-Extremity Ulcers. N Engl J Med. 2017 Oct 19;377(16):1559-1567. [PubMed]
22. Bonne SL, Kadri SS. Evaluation and Management of Necrotizing Soft Tissue Infections. Infect Dis Clin North Am. 2017 Sep;31(3):497-511. [PMC free article] [PubMed]
23. Warkentin TE. Ischemic Limb Gangrene with Pulses. N Engl J Med. 2015 Aug 13;373(7):642-55. [PubMed]
24. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75. [PubMed]
25. Roach AN, Kwong R, Sylvester S. Emergence of Invasive Group A Streptococcus Infection in an Infant: A Case Report. Clin Pract Cases Emerg Med. 2025 Jan;9(1):45-48. [PMC free article] [PubMed]
26. Henn MC, Hathaway BA, Lipira AB. Reconstructive Surgical Management of Vasopressor-Ischemia Related Distal Extremity Loss. J Orthop Case Rep. 2025 Apr;15(4):45-51. [PMC free article] [PubMed]
27. Schreuder SM, Hendrix YMGA, Reekers JA, Bipat S. Predictive Parameters for Clinical Outcome in Patients with Critical Limb Ischemia Who Underwent Percutaneous Transluminal Angioplasty (PTA): A Systematic Review. Cardiovasc Intervent Radiol. 2018 Jan;41(1):1-20. [PMC free article] [PubMed]
28. Landry GJ. Functional outcome of critical limb ischemia. J Vasc Surg. 2007 Jun;45 Suppl A:A141-8. [PubMed]
29. Determann C, Walker CA. Clostridium perfringens gas gangrene at a wrist intravenous line insertion. BMJ Case Rep. 2013 Oct 09;2013 [PMC free article] [PubMed]